GDNF family receptor alpha 1–Neural cell adhesion molecule complex (GFRα1–NCAM complex)

The GDNF family receptor alpha 1–Neural cell adhesion molecule (GFRα1–NCAM) complex is a specialized signaling assembly that mediates the effects of glial cell-derived neurotrophic factor (GDNF) independently of the RET receptor tyrosine kinase (Paratcha et al., 2003, Cell). In this complex, GFRα1 (UniProt: P56159) acts as the high-affinity ligand-binding component, while NCAM (UniProt: P13591) serves as the transmembrane signaling scaffold. Upon GDNF binding, the complex activates intracellular pathways, most notably the Fyn/FAK signaling cascade, which is crucial for neurite outgrowth, synapse formation, and Schwann cell migration (Bespalov et al., 2011, Frontiers in Molecular Neuroscience). This pathway is particularly significant in the central and peripheral nervous systems where RET expression is low or absent, providing an alternative mechanism for neurotrophic support. Therapeutically, the GFRα1–NCAM complex is a target for treating neurodegenerative conditions like Parkinson's disease and peripheral nerve injuries, as it promotes neuronal survival and structural plasticity (Sidorova et al., 2010, Molecular and Cellular Neuroscience). Current pharmacological strategies focus on GDNF mimetics and small molecules, such as BT13, that can selectively activate this complex to bypass the delivery and stability limitations of protein-based therapies (Sidorova et al., 2017, Scientific Reports).

Other names

GFRalpha1-NCAM complexGDNFR-alpha-NCAM complexRET-independent GDNF receptor complexGDNF-GFRα1-NCAM signaling assembly

Binding of GDNF to GFRα1 induces its association with NCAM, triggering the activation of intracellular signaling cascades such as the Fyn/FAK pathway to promote neuronal survival and differentiation (Paratcha et al., 2003, Cell).